Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials
Matteo Clavarezza, Matteo Puntoni, Alessandra Gennari, Laura Paleari, Nicoletta Provinciali, Mauro D'Amico, Andrea DeCensi
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials'. Together they form a unique fingerprint.